9.64
Schlusskurs vom Vortag:
$9.95
Offen:
$9.9
24-Stunden-Volumen:
1.34M
Relative Volume:
1.15
Marktkapitalisierung:
$728.33M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-3.9347
EPS:
-2.45
Netto-Cashflow:
$-64.37M
1W Leistung:
+19.45%
1M Leistung:
+36.74%
6M Leistung:
+37.62%
1J Leistung:
+11.96%
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MNMD
Mind Medicine Inc
|
9.64 | 609.71M | 11.40B | -95.73M | -64.37M | -2.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-28 | Eingeleitet | Evercore ISI | Outperform |
2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
2024-10-14 | Fortgesetzt | Leerink Partners | Outperform |
2024-07-24 | Eingeleitet | ROTH MKM | Buy |
2024-05-29 | Eingeleitet | Robert W. Baird | Outperform |
2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
2023-12-05 | Eingeleitet | Canaccord Genuity | Buy |
2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-05-04 | Eingeleitet | ROTH Capital | Buy |
2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
What analysts say about Mind Medicine (MindMed) Inc. stockExplosive capital appreciation - jammulinksnews.com
Mind Medicine (MindMed) Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy - Yahoo Finance
Is Mind Medicine (MindMed) Inc. a good long term investmentTriple returns potential - jammulinksnews.com
Mind Medicine (MindMed) Stock (MNMD) Opinions on Psychedelic Therapy Political Momentum - Nasdaq
What risks could impact Mind Medicine (MindMed) Inc. stock performanceFree Stock Market Beginners Guide - beatles.ru
(MNMD) Trading Signals - news.stocktradersdaily.com
What drives Mind Medicine (MindMed) Inc. stock priceLightning-fast capital gains - jammulinksnews.com
Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money
Mind Medicine stock rises as lawmakers discuss psychedelic therapy for veterans - Investing.com Canada
MindMed Announces New Employee Inducement Grants - Business Wire
Evercore ISI Sticks to Its Buy Rating for Mind Medicine (MNMD) - The Globe and Mail
Mind Medicine Inc.(NasdaqGS: MNMD) added to Russell 3000E Value Index - MarketScreener
Mind Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Psychedelic medicine stocks fall following Compass depression asset data (ATAI:NASDAQ) - Seeking Alpha
(MNMD) Trading Report - news.stocktradersdaily.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com South Africa
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry By Investing.com - Investing.com Canada
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Mind Medicine Shareholders Approve Key Proposals at Annual Meeting - TipRanks
Analysts Offer Predictions for MNMD FY2026 Earnings - Defense World
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Two Sigma Advisers LP Buys 5,400 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Ameriprise Financial Inc. Takes Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
(MNMD) Investment Report - news.stocktradersdaily.com
Millennium Management LLC Increases Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances - Investing.com Australia
MindMed at Jefferies Global Healthcare Conference: Psychedelic Drug Advances By Investing.com - Investing.com UK
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Sold by Two Sigma Investments LP - Defense World
Why Mind Medicine Gave Investors a Powerful Buzz in May - AOL.com
Bank of America Corp DE Reduces Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Why is Mind Medicine (MNMD) Stock Moving Today? - GuruFocus
Why Mind Medicine Gave Investors A Powerful Buzz In May - Barchart.com
Nuveen Asset Management LLC Acquires 8,856 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade - MSN
Mind Medicine (MNMD) Initiated with a Buy at Oppenheimer - The Globe and Mail
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):